نتائج البحث 1731-1740 من 19780 لعملية البحث عن Two-phase
This is a phase II multi-center study of nab-paclitaxel, gemcitabine and cisplatin (NGC triple regimen) as preoperative therapy in potentially resectable ...
... 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated ... (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype ...
... (2) Cohort 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated calreticulin (muCALR); (3) Cohort 3 focuses on glioblastoma multiforme ...
... Phase 1/2 study in a selected cohort of patient with LM. Prehabilitation. Rochester, Minn. Physical activity plays an important role in reducing the adverse ...
... Stage 4 breast cancer, BRCA gene mutation ... 2 laser treatment, Conization, Polypectomy, HPV ... توجّه للصفحة 22. طلب تحديد موعد · الحلات التي يتم ...
The second objective is to continue to identify whether there is a genetic link associated with MacTel Type 2. All participants who have not previously provided ...
... 2-hydroxyglutarate (2HG) and, therefore, differentiate ... two cycles of mosunetuzumab. An additional arm ... MC1733, Phase I Trial of Intratumoral ...
The purpose of this study is to assess outcomes, satisfaction and aesthetics of two different breast reconstruction techniques (Goldilocks alone, and ...
This study may help doctors determine if the two surgical procedures are nearly the same for ovarian cancer risk reduction for women with BRCA1 mutations. A ...
This phase I trial studies the best dose and side ... 2 drugs for the initial WT) and regimen ICE/Cyclo ... 2-year progression free survival (PFS) rate as compared ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.